JPX · 6857.T
Advantest Corporation
¥33,720-¥3,310 (-8.94%)
Advantest Corporation’s quoted price sits in the upper half of its reported 52-week range, 19.7% below the high.
Loading market information…
NASDAQ · TER · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Teradyne, Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.29% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Teradyne, Inc.’s forward annual dividend is $0.52 per share, paid quarterly. The forward yield is 0.18% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Teradyne, Inc.’s next earnings report is currently expected on Jan 27, 2027, with estimated earnings per share of $2.07. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Teradyne, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Teradyne, Inc., established in 1960 and headquartered in North Reading, Massachusetts, is a global leader specializing in the creation, production, sale, and maintenance of automated testing solutions. The company's operations are categorized into four principal divisions: 1. Semiconductor Test: This segment delivers solutions for testing microchips at both the wafer and finished device package stages. These capabilities serve a wide array of sectors, including automotive, industrial, telecommunications, consumer electronics, mobile devices, cloud computing, and gaming. Notable offerings include the FLEX test platform, the J750 system for high-volume semiconductor testing, the Magnum platform specialized for memory components like flash and DRAM, and the ETS platform, which caters to the analog/mixed-signal markets for chip makers and outsourced assembly/test providers. Its clientele encompasses integrated device manufacturers (IDMs), fabless chip companies, foundries, and independent semiconductor assembly and test firms. 2. System Test: This division provides instrumentation and systems for defense and aerospace applications, data storage testing apparatus, and solutions for circuit board examination and fault detection. 3. Industrial Automation: This segment supplies collaborative robotic arms, self-governing mobile robots, and sophisticated software for robotic control, primarily catering to clients in manufacturing, logistics, and lighter industrial applications. 4. Wireless Test: Operating under its LitePoint brand, this segment delivers crucial testing solutions for the development and production of various wireless products, ranging from modules and smartphones to tablets, laptops, peripherals, and Internet-of-Things (IoT) gadgets. Key offerings include IQxel for Wi-Fi and other connectivity standards, IQxstream for comprehensive cellular technology testing (including 5G), IQcell for multi-device cellular signaling verification, IQgig, and ready-to-use test software tailored for wireless chipsets.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 |
|---|
| Jul 29, 2025 |
| $0.57+5.17% vs estimate |
| $651.80M+0.18% vs estimate |
| Q1 2025 | Apr 28, 2025 | $0.75+21.16% vs estimate | $685.68M+0.76% vs estimate |
|---|
| Q4 2024 | Jan 29, 2025 | $0.95+4.4% vs estimate | $752.88M+1.62% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
31 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 7 contributors · Median target $440.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥33,720-¥3,310 (-8.94%)
Advantest Corporation’s quoted price sits in the upper half of its reported 52-week range, 19.7% below the high.
$329.84-$5.66 (-1.69%)
Keysight Technologies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 15.41% below the high.
$221.89-$1.79 (-0.8%)
Onto Innovation Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.58% below the high.
$97.46-$12.85 (-11.65%)
FormFactor, Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.19% below the high.
$126.67-$2.11 (-1.64%)
Camtek Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.35% below the high.
NT$4,655.00-NT$280.00 (-5.67%)
WinWay Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 59.49% below the high.
$53.40+$0.26 (+0.49%)
Cohu, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.48% below the high.
$61.21-$3.33 (-5.16%)
Aehr Test Systems’s quoted price sits in the lower half of its reported 52-week range, 58.47% below the high.
